TheIEM Mobil-O-Graph with analysis software is a highly intuitive 24 hour Ambulatory Blood Pressure Monitor (ABPM).
Among 24hr ABPM devices, the Mobil-O-Graph® NG is clearly one of the classics worldwide and has become one of the most popular long-term blood pressure monitors for the medical practice or clinic. Its particularly gentle measurement method results in very high patient acceptance levels and greater patient compliance. Its quick and easy management within the daily practice routine combined with hypertension management software has made the Mobil-O-Graph® NG one of the most popular long-term blood pressure monitors. The extensive accessories available and its sturdiness due to “Made in Germany” quality make it popular among patients and doctors alike.
As recommended by NICE, recording a patient’s blood pressure during their everyday routine gives a more accurate blood pressure profile free from distortion created by white coat hypertension. This allows a more accurate diagnosis to be made. The Mobil-O-Graph can record ambulatory blood pressure for up to 48 hours.
The product benefits • Gentler and faster blood pressure monitoring thanks to AF® logic • 24/48hr monitoring or hospital monitoring in the event of hypertensive crises • Day/night button ensures accurate assignment of the measurements • Ease of handling within the practice/clinic and high measurement quality (validated according to BHS (A/A grading) and ESH) • Interface with all standard practice management programs, HL7 (hospital information system) and GDT
In ambulatory pulse wave monitoring, the peripheral blood pressure, the central hemodynamics, and the arterial stiffness are automatically measured over a period of 24 hours at an interval that can be freely adjusted. This can be used to create a hemodynamic day/night profile.
Primary care physicians are in a pivotal position within the healthcare system to improve the standard of care for patients with PAD. This improvement can be achieved if physicians follow guidelines and measure ABI on all patients in the cardiovascular risk group, regardless of presenting symptoms.
According to new 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS), “it is theoutmostimportance that every cardiologist should be sensitive to the diagnosis and management of patients with PADs,…”
Measurements of the Ankle-Brachial Index may improve the accuracy of cardiovascular risk prediction beyond the Framingham Risk Score. Furthermore, ABI is valuable for assessing the ability of rehabilitation after cardiac procedures or treatment.
Dermatology, Compression therapy and wound care management
Ankle-Brachial Index should be the first measurement in wound care, to predict the heal-ability of lower leg wounds. It rules out arterial condition and therefore determines the safe level of compression.
Kidney disease is an independent risk factor for the development of PAD. According to KDOQI guidelines, all patients should be evaluated for PAD at the time of dialysis. The disease in those patients progresses faster than in patients without kidney disease.
Ankle-Brachial Index (ABI) is used as a screening tool to determine the possible presence of Peripheral Arterial Disease (PAD)and therefore indicate further management. It is especially useful in the post-operative care of revascularized patients.
A screening Ankle-Brachial Index (ABI) should be considered in diabetic patients above 50 years of age who have other PAD risk factors (e.g., smoking, hypertension, hyperlipidemia, or duration of diabetes for 10 years). If ABI is normal, the measurement has to be repeated every five years.
Measurements of the Ankle-Brachial Index are essential in the differential diagnosis of lower extremity pain. In addition, a recurrent ischemia associated with PAD may cause muscle denervation, which may be one of the mechanisms responsible for decreased exercise performance in these patients.